Merck & Co. MRK Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Merck & Co.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Merck & Co.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Merck & Co.'s change in accrued liabilities?
- Merck & Co. (MRK) reported change in accrued liabilities of -$460.25M in Q4 2025.
- How has Merck & Co.'s change in accrued liabilities changed year-over-year?
- Merck & Co.'s change in accrued liabilities increased by 20.9% year-over-year, from -$582M to -$460.25M.
- What is the long-term trend for Merck & Co.'s change in accrued liabilities?
- Over 4 years (2021 to 2025), Merck & Co.'s change in accrued liabilities has grown at a 60.6% compound annual growth rate (CAGR), from $277M to -$1.84B.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.